Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
@article{206150,
author = {Seerat Manzoor and Sadaf Abusad and Mousin Nissar Ahanger and Sonu Chauhan and RIFAT ATAULLAH},
title = {Brain Tumours and Glioblastoma Multiform:A Comprehensive clinical review with Case Based Analysis e},
journal = {International Journal of Innovative Research in Technology},
year = {2026},
volume = {13},
number = {2},
pages = {673-680},
issn = {2349-6002},
url = {https://ijirt.org/article?manuscript=206150},
abstract = {Brain tumours represent a heterogeneous group of intracranial neoplasms with widely varying biological behaviour, clinical presentation, and prognosis. Among them, Glioblastoma Multiforme (GBM) — classified as WHO Grade IV astrocytoma — remains the most aggressive and lethal primary brain tumour in adults, with a median overall survival of 14–16 months even with optimal multimodal therapy. This review consolidates current knowledge on the classification, pathophysiology, clinical presentation, neuroimaging characteristics, pharmacological management, and supportive care of brain tumours, with particular emphasis on GBM. A real-life case study of a 75-year-old female patient presenting with first-time generalised tonic-clonic seizures, subsequently diagnosed with GBM via MRI with spectroscopy, is analysed in depth. The case highlights the critical role of early neuroimaging, interpretation of MR spectroscopy findings, dual anti-epileptic pharmacotherapy (Levetiracetam+Lacosamide),corticosteroid use for cerebral oedema management, and the indispensable human dimension of oncological care including family counseling .The patient's clinical course— from first seizure to death in just 96 days — underscores the devastating natural history of GBM and the urgent need for heightened awareness, early diagnosis, and multidisciplinary management.},
keywords = {Glioblastoma Multiforme, Brain Tumour, Seizure, MRI Spectroscopy, Levetiracetam, Lacosamide, Methylprednisolone, Intracranial Pressure, Cerebral Oedema, Neuro-oncology, Temozolomide, Multimodal Therapy},
month = {July},
}
Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.
Join NowNational Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024
Submit inquiry